STRATA Skin Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	30.7	33.56	33.36	36.16	29.98
Revenue Growth (YoY)	-8.54%	0.61%	-7.75%	20.63%	29.83%
Cost of Revenue	12.82	14.34	14.9	14.39	10.13
Gross Profit	17.88	19.22	18.46	21.77	19.85
Selling, General & Admin	23.3	23.33	23.46	25.39	22.82
Research & Development	0.42	0.88	1.32	1.03	1.43
Operating Expenses	23.72	24.21	24.78	26.42	24.25
Operating Income	-5.84	-4.99	-6.32	-4.65	-4.4
Interest Expense	-1.96	-2.11	-1.64	-0.93	-0.31
Interest & Investment Income	0.41	0.24	0.23	0.09	0.02
EBT Excluding Unusual Items	-7.38	-6.85	-7.73	-5.49	-4.7
Impairment of Goodwill	-	-4.27	-2.28	-	-
Other Unusual Items	1.14	0.86	-0.91	-	2.03
Pretax Income	-6.25	-10.26	-10.92	-5.49	-2.67
Income Tax Expense	0.01	-0.17	-0.09	0.06	0.03
Net Income	-6.26	-10.09	-10.83	-5.55	-2.71
Net Income to Common	-6.26	-10.09	-10.83	-5.55	-2.71
Shares Outstanding (Basic)	5	4	3	3	3
Shares Outstanding (Diluted)	5	4	3	3	3
Shares Change (YoY)	22.15%	9.03%	0.60%	1.94%	1.31%
EPS (Basic)	-1.35	-2.65	-3.10	-1.60	-0.79
EPS (Diluted)	-1.35	-2.65	-3.10	-1.60	-0.79
Free Cash Flow	-4.26	-1.45	-5.54	-4.66	-2.15
Free Cash Flow Per Share	-0.92	-0.38	-1.59	-1.34	-0.63
Gross Margin	58.25%	57.27%	55.34%	60.20%	66.22%
Operating Margin	-19.01%	-14.86%	-18.95%	-12.86%	-14.69%
Profit Margin	-20.40%	-30.05%	-32.47%	-15.35%	-9.03%
Free Cash Flow Margin	-13.88%	-4.31%	-16.60%	-12.89%	-7.16%
EBITDA	-1.71	-0.02	-0.77	0.64	-0.67
EBITDA Margin	-5.58%	-0.06%	-2.30%	1.78%	-2.22%
D&A For EBITDA	4.12	4.97	5.55	5.29	3.74
EBIT	-5.84	-4.99	-6.32	-4.65	-4.4
EBIT Margin	-19.01%	-14.86%	-18.95%	-12.86%	-14.68%
Advertising Expenses	0.8	1	0.5	1.6	1.6